Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Free Cash Flow (2016 - 2018)

Armata Pharmaceuticals' Free Cash Flow history spans 6 years, with the latest figure at -$3.6 million for Q4 2018.

  • For Q4 2018, Free Cash Flow fell 50.23% year-over-year to -$3.6 million; the TTM value through Dec 2018 reached -$11.2 million, down 20.79%, while the annual FY2024 figure was -$39.4 million, 29.04% up from the prior year.
  • Free Cash Flow for Q4 2018 was -$3.6 million at Armata Pharmaceuticals, down from -$2.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$626000.0 in Q3 2017 and bottomed at -$3.9 million in Q1 2014.
  • The 5-year median for Free Cash Flow is -$3.0 million (2016), against an average of -$2.8 million.
  • The largest annual shift saw Free Cash Flow crashed 250.31% in 2014 before it surged 80.19% in 2017.
  • A 5-year view of Free Cash Flow shows it stood at -$3.2 million in 2014, then grew by 26.99% to -$2.3 million in 2015, then surged by 35.43% to -$1.5 million in 2016, then plummeted by 57.97% to -$2.4 million in 2017, then tumbled by 50.23% to -$3.6 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Free Cash Flow are -$3.6 million (Q4 2018), -$2.2 million (Q3 2018), and -$1.9 million (Q2 2018).